nodes	percent_of_prediction	percent_of_DWPC	metapath
Nitric Oxide—CYP3A4—prostate cancer	0.183	1	CbGaD
Nitric Oxide—CYP2B6—Estrone—prostate cancer	0.0535	0.109	CbGbCtD
Nitric Oxide—CYP3A4—Estradiol valerate/Dienogest—prostate cancer	0.0522	0.106	CbGbCtD
Nitric Oxide—CYP2B6—Ethinyl Estradiol—prostate cancer	0.0477	0.0968	CbGbCtD
Nitric Oxide—CYP1A2—Flutamide—prostate cancer	0.0434	0.0881	CbGbCtD
Nitric Oxide—CYP1A2—Estrone—prostate cancer	0.0313	0.0637	CbGbCtD
Nitric Oxide—CYP3A4—Bicalutamide—prostate cancer	0.0274	0.0557	CbGbCtD
Nitric Oxide—CYP3A4—Estramustine—prostate cancer	0.0255	0.0518	CbGbCtD
Nitric Oxide—CYP3A4—Flutamide—prostate cancer	0.0227	0.0462	CbGbCtD
Nitric Oxide—CYP3A4—Abiraterone—prostate cancer	0.0227	0.0462	CbGbCtD
Nitric Oxide—CYP1A2—Conjugated Estrogens—prostate cancer	0.0205	0.0417	CbGbCtD
Nitric Oxide—CYP1A2—Estradiol—prostate cancer	0.018	0.0366	CbGbCtD
Nitric Oxide—CYP3A4—Cabazitaxel—prostate cancer	0.0168	0.0341	CbGbCtD
Nitric Oxide—CYP3A4—Estrone—prostate cancer	0.0164	0.0334	CbGbCtD
Nitric Oxide—CYP3A4—Ethinyl Estradiol—prostate cancer	0.0146	0.0297	CbGbCtD
Nitric Oxide—CYP2B6—Doxorubicin—prostate cancer	0.0137	0.0278	CbGbCtD
Nitric Oxide—CYP1A2—Etoposide—prostate cancer	0.0118	0.0239	CbGbCtD
Nitric Oxide—CYP3A4—Conjugated Estrogens—prostate cancer	0.0107	0.0218	CbGbCtD
Nitric Oxide—CYP3A4—Mitoxantrone—prostate cancer	0.00977	0.0198	CbGbCtD
Nitric Oxide—CYP3A4—Estradiol—prostate cancer	0.00943	0.0192	CbGbCtD
Nitric Oxide—CYP3A4—Prednisone—prostate cancer	0.00811	0.0165	CbGbCtD
Nitric Oxide—Methaemoglobinaemia—Flutamide—prostate cancer	0.00806	0.0704	CcSEcCtD
Nitric Oxide—CYP3A4—Etoposide—prostate cancer	0.00616	0.0125	CbGbCtD
Nitric Oxide—CYP3A4—Docetaxel—prostate cancer	0.00564	0.0114	CbGbCtD
Nitric Oxide—GUCY1A2—prostate gland—prostate cancer	0.0055	0.087	CbGeAlD
Nitric Oxide—Cerebral infarction—Ethinyl Estradiol—prostate cancer	0.00446	0.0389	CcSEcCtD
Nitric Oxide—CYP3A4—Doxorubicin—prostate cancer	0.0042	0.00853	CbGbCtD
Nitric Oxide—Methaemoglobinaemia—Conjugated Estrogens—prostate cancer	0.00403	0.0352	CcSEcCtD
Nitric Oxide—CYP1A2—urine—prostate cancer	0.00381	0.0602	CbGeAlD
Nitric Oxide—GUCY1A3—prostate gland—prostate cancer	0.00346	0.0548	CbGeAlD
Nitric Oxide—GUCY1B3—prostate gland—prostate cancer	0.00344	0.0544	CbGeAlD
Nitric Oxide—Chest discomfort—Abiraterone—prostate cancer	0.00294	0.0257	CcSEcCtD
Nitric Oxide—GUCY1A3—seminal vesicle—prostate cancer	0.00293	0.0463	CbGeAlD
Nitric Oxide—ALDH2—prostate gland—prostate cancer	0.00292	0.0462	CbGeAlD
Nitric Oxide—GUCY1B3—seminal vesicle—prostate cancer	0.00291	0.046	CbGeAlD
Nitric Oxide—CYP3A4—urine—prostate cancer	0.00276	0.0436	CbGeAlD
Nitric Oxide—ALDH2—seminal vesicle—prostate cancer	0.00247	0.039	CbGeAlD
Nitric Oxide—GUCY1A2—testis—prostate cancer	0.00242	0.0383	CbGeAlD
Nitric Oxide—GUCY1A3—renal system—prostate cancer	0.00236	0.0373	CbGeAlD
Nitric Oxide—GUCY1B3—renal system—prostate cancer	0.00234	0.0371	CbGeAlD
Nitric Oxide—GUCY1A3—urethra—prostate cancer	0.00232	0.0367	CbGeAlD
Nitric Oxide—Dry throat—Estradiol—prostate cancer	0.00231	0.0202	CcSEcCtD
Nitric Oxide—GUCY1B3—urethra—prostate cancer	0.0023	0.0364	CbGeAlD
Nitric Oxide—Haemorrhage intracranial—Mitoxantrone—prostate cancer	0.00215	0.0188	CcSEcCtD
Nitric Oxide—ALDH2—renal system—prostate cancer	0.00199	0.0315	CbGeAlD
Nitric Oxide—ALDH2—urethra—prostate cancer	0.00195	0.0309	CbGeAlD
Nitric Oxide—Gastrointestinal haemorrhage—Estramustine—prostate cancer	0.00195	0.017	CcSEcCtD
Nitric Oxide—GUCY1A3—bone marrow—prostate cancer	0.00179	0.0282	CbGeAlD
Nitric Oxide—GUCY1B3—bone marrow—prostate cancer	0.00177	0.028	CbGeAlD
Nitric Oxide—GUCY1A2—lymph node—prostate cancer	0.00176	0.0278	CbGeAlD
Nitric Oxide—Gastrointestinal haemorrhage—Nilutamide—prostate cancer	0.00173	0.0151	CcSEcCtD
Nitric Oxide—GUCY1A3—testis—prostate cancer	0.00153	0.0241	CbGeAlD
Nitric Oxide—GUCY1B3—testis—prostate cancer	0.00151	0.024	CbGeAlD
Nitric Oxide—ALDH2—bone marrow—prostate cancer	0.0015	0.0238	CbGeAlD
Nitric Oxide—Gastrointestinal haemorrhage—Cabazitaxel—prostate cancer	0.00145	0.0127	CcSEcCtD
Nitric Oxide—ALDH2—testis—prostate cancer	0.00129	0.0203	CbGeAlD
Nitric Oxide—Cardiac disorder—Abiraterone—prostate cancer	0.00121	0.0106	CcSEcCtD
Nitric Oxide—Pneumothorax—Capecitabine—prostate cancer	0.00119	0.0104	CcSEcCtD
Nitric Oxide—Angiopathy—Abiraterone—prostate cancer	0.00119	0.0104	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Abiraterone—prostate cancer	0.00118	0.0103	CcSEcCtD
Nitric Oxide—GUCY1A3—lymph node—prostate cancer	0.00111	0.0175	CbGeAlD
Nitric Oxide—GUCY1B3—lymph node—prostate cancer	0.0011	0.0174	CbGeAlD
Nitric Oxide—Chest discomfort—Estradiol—prostate cancer	0.00107	0.00935	CcSEcCtD
Nitric Oxide—Cardiac disorder—Estradiol valerate/Dienogest—prostate cancer	0.00104	0.0091	CcSEcCtD
Nitric Oxide—Chest pain—Estramustine—prostate cancer	0.000998	0.00872	CcSEcCtD
Nitric Oxide—Cardiac disorder—Degarelix—prostate cancer	0.000991	0.00866	CcSEcCtD
Nitric Oxide—Chest pain—Abiraterone—prostate cancer	0.00097	0.00847	CcSEcCtD
Nitric Oxide—Angiopathy—Degarelix—prostate cancer	0.000969	0.00846	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Degarelix—prostate cancer	0.000962	0.00841	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Estramustine—prostate cancer	0.000937	0.00819	CcSEcCtD
Nitric Oxide—Cardiac disorder—Cabazitaxel—prostate cancer	0.000934	0.00815	CcSEcCtD
Nitric Oxide—ALDH2—lymph node—prostate cancer	0.000932	0.0147	CbGeAlD
Nitric Oxide—CYP1A2—renal system—prostate cancer	0.000932	0.0147	CbGeAlD
Nitric Oxide—Angiopathy—Cabazitaxel—prostate cancer	0.000913	0.00797	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Cabazitaxel—prostate cancer	0.000907	0.00792	CcSEcCtD
Nitric Oxide—CYP2B6—renal system—prostate cancer	0.000893	0.0141	CbGeAlD
Nitric Oxide—Chest pain—Nilutamide—prostate cancer	0.000886	0.00774	CcSEcCtD
Nitric Oxide—Bradycardia—Bicalutamide—prostate cancer	0.000878	0.00767	CcSEcCtD
Nitric Oxide—Haemoglobin—Bicalutamide—prostate cancer	0.000867	0.00758	CcSEcCtD
Nitric Oxide—Haemorrhage—Bicalutamide—prostate cancer	0.000863	0.00754	CcSEcCtD
Nitric Oxide—Dyspnoea—Estramustine—prostate cancer	0.000853	0.00745	CcSEcCtD
Nitric Oxide—Shock—Nilutamide—prostate cancer	0.000836	0.0073	CcSEcCtD
Nitric Oxide—Chest discomfort—Etoposide—prostate cancer	0.00083	0.00725	CcSEcCtD
Nitric Oxide—Dyspnoea—Abiraterone—prostate cancer	0.000829	0.00724	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Flutamide—prostate cancer	0.000828	0.00723	CcSEcCtD
Nitric Oxide—Pneumothorax—Epirubicin—prostate cancer	0.000827	0.00723	CcSEcCtD
Nitric Oxide—Cardiac disorder—Bicalutamide—prostate cancer	0.000801	0.007	CcSEcCtD
Nitric Oxide—Angiopathy—Bicalutamide—prostate cancer	0.000783	0.00684	CcSEcCtD
Nitric Oxide—Nervous system disorder—Estradiol valerate/Dienogest—prostate cancer	0.000783	0.00683	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Bicalutamide—prostate cancer	0.000778	0.00679	CcSEcCtD
Nitric Oxide—Pneumothorax—Doxorubicin—prostate cancer	0.000766	0.00669	CcSEcCtD
Nitric Oxide—Dyspnoea—Nilutamide—prostate cancer	0.000757	0.00661	CcSEcCtD
Nitric Oxide—Chest pain—Cabazitaxel—prostate cancer	0.000745	0.00651	CcSEcCtD
Nitric Oxide—Nervous system disorder—Degarelix—prostate cancer	0.000744	0.0065	CcSEcCtD
Nitric Oxide—Haemoglobin—Ethinyl Estradiol—prostate cancer	0.000733	0.0064	CcSEcCtD
Nitric Oxide—Haemorrhage—Ethinyl Estradiol—prostate cancer	0.000729	0.00637	CcSEcCtD
Nitric Oxide—Hypotension—Degarelix—prostate cancer	0.000709	0.00619	CcSEcCtD
Nitric Oxide—Nervous system disorder—Cabazitaxel—prostate cancer	0.000701	0.00612	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Cabazitaxel—prostate cancer	0.0007	0.00611	CcSEcCtD
Nitric Oxide—Chest discomfort—Docetaxel—prostate cancer	0.00069	0.00603	CcSEcCtD
Nitric Oxide—Dyspnoea—Degarelix—prostate cancer	0.000676	0.00591	CcSEcCtD
Nitric Oxide—CYP3A4—renal system—prostate cancer	0.000674	0.0107	CbGeAlD
Nitric Oxide—Chest discomfort—Capecitabine—prostate cancer	0.000668	0.00583	CcSEcCtD
Nitric Oxide—Hypotension—Cabazitaxel—prostate cancer	0.000668	0.00583	CcSEcCtD
Nitric Oxide—Angiopathy—Ethinyl Estradiol—prostate cancer	0.000662	0.00578	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Mitoxantrone—prostate cancer	0.000641	0.0056	CcSEcCtD
Nitric Oxide—Chest pain—Bicalutamide—prostate cancer	0.00064	0.00559	CcSEcCtD
Nitric Oxide—Dyspnoea—Cabazitaxel—prostate cancer	0.000637	0.00557	CcSEcCtD
Nitric Oxide—Dizziness—Estrone—prostate cancer	0.000605	0.00528	CcSEcCtD
Nitric Oxide—Haemoglobin—Goserelin—prostate cancer	0.000603	0.00527	CcSEcCtD
Nitric Oxide—Shock—Bicalutamide—prostate cancer	0.000603	0.00527	CcSEcCtD
Nitric Oxide—Nervous system disorder—Bicalutamide—prostate cancer	0.000601	0.00525	CcSEcCtD
Nitric Oxide—Haemorrhage—Goserelin—prostate cancer	0.0006	0.00524	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Bicalutamide—prostate cancer	0.0006	0.00524	CcSEcCtD
Nitric Oxide—Headache—Estramustine—prostate cancer	0.0006	0.00524	CcSEcCtD
Nitric Oxide—CYP2B6—testis—prostate cancer	0.000577	0.00913	CbGeAlD
Nitric Oxide—Headache—Estrone—prostate cancer	0.000573	0.005	CcSEcCtD
Nitric Oxide—Dizziness—Nilutamide—prostate cancer	0.000562	0.00491	CcSEcCtD
Nitric Oxide—Dizziness—Flutamide—prostate cancer	0.000559	0.00488	CcSEcCtD
Nitric Oxide—Cardiac disorder—Goserelin—prostate cancer	0.000557	0.00487	CcSEcCtD
Nitric Oxide—Cardiac disorder—Conjugated Estrogens—prostate cancer	0.000552	0.00482	CcSEcCtD
Nitric Oxide—Dyspnoea—Bicalutamide—prostate cancer	0.000547	0.00477	CcSEcCtD
Nitric Oxide—Angiopathy—Goserelin—prostate cancer	0.000545	0.00476	CcSEcCtD
Nitric Oxide—Angiopathy—Conjugated Estrogens—prostate cancer	0.000539	0.00471	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Conjugated Estrogens—prostate cancer	0.000536	0.00468	CcSEcCtD
Nitric Oxide—Headache—Nilutamide—prostate cancer	0.000532	0.00465	CcSEcCtD
Nitric Oxide—Headache—Flutamide—prostate cancer	0.00053	0.00463	CcSEcCtD
Nitric Oxide—Dizziness—Estradiol valerate/Dienogest—prostate cancer	0.000528	0.00461	CcSEcCtD
Nitric Oxide—Nervous system disorder—Ethinyl Estradiol—prostate cancer	0.000508	0.00444	CcSEcCtD
Nitric Oxide—Dizziness—Degarelix—prostate cancer	0.000502	0.00438	CcSEcCtD
Nitric Oxide—Headache—Estradiol valerate/Dienogest—prostate cancer	0.0005	0.00437	CcSEcCtD
Nitric Oxide—Haemoglobin—Estradiol—prostate cancer	0.000478	0.00418	CcSEcCtD
Nitric Oxide—Haemorrhage—Estradiol—prostate cancer	0.000476	0.00416	CcSEcCtD
Nitric Oxide—Headache—Degarelix—prostate cancer	0.000475	0.00415	CcSEcCtD
Nitric Oxide—Dizziness—Cabazitaxel—prostate cancer	0.000473	0.00413	CcSEcCtD
Nitric Oxide—Convulsion—Goserelin—prostate cancer	0.000453	0.00395	CcSEcCtD
Nitric Oxide—Bradycardia—Mitoxantrone—prostate cancer	0.000451	0.00394	CcSEcCtD
Nitric Oxide—Convulsion—Conjugated Estrogens—prostate cancer	0.000448	0.00392	CcSEcCtD
Nitric Oxide—Headache—Cabazitaxel—prostate cancer	0.000448	0.00391	CcSEcCtD
Nitric Oxide—Haemoglobin—Mitoxantrone—prostate cancer	0.000446	0.00389	CcSEcCtD
Nitric Oxide—Chest pain—Goserelin—prostate cancer	0.000445	0.00389	CcSEcCtD
Nitric Oxide—Haemorrhage—Mitoxantrone—prostate cancer	0.000443	0.00387	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Docetaxel—prostate cancer	0.000443	0.00387	CcSEcCtD
Nitric Oxide—Cardiac disorder—Estradiol—prostate cancer	0.000442	0.00386	CcSEcCtD
Nitric Oxide—Chest pain—Conjugated Estrogens—prostate cancer	0.000441	0.00385	CcSEcCtD
Nitric Oxide—Angiopathy—Estradiol—prostate cancer	0.000432	0.00377	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Capecitabine—prostate cancer	0.000429	0.00375	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Estradiol—prostate cancer	0.000429	0.00375	CcSEcCtD
Nitric Oxide—Shock—Goserelin—prostate cancer	0.00042	0.00366	CcSEcCtD
Nitric Oxide—Nervous system disorder—Goserelin—prostate cancer	0.000418	0.00365	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Goserelin—prostate cancer	0.000418	0.00365	CcSEcCtD
Nitric Oxide—Shock—Conjugated Estrogens—prostate cancer	0.000416	0.00363	CcSEcCtD
Nitric Oxide—Nervous system disorder—Conjugated Estrogens—prostate cancer	0.000414	0.00362	CcSEcCtD
Nitric Oxide—Dizziness—Bicalutamide—prostate cancer	0.000405	0.00354	CcSEcCtD
Nitric Oxide—Hypotension—Goserelin—prostate cancer	0.000399	0.00348	CcSEcCtD
Nitric Oxide—Hypotension—Conjugated Estrogens—prostate cancer	0.000395	0.00345	CcSEcCtD
Nitric Oxide—Headache—Bicalutamide—prostate cancer	0.000384	0.00335	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Prednisone—prostate cancer	0.000382	0.00334	CcSEcCtD
Nitric Oxide—Dyspnoea—Goserelin—prostate cancer	0.00038	0.00332	CcSEcCtD
Nitric Oxide—Dyspnoea—Conjugated Estrogens—prostate cancer	0.000377	0.00329	CcSEcCtD
Nitric Oxide—Chest pain—Estradiol—prostate cancer	0.000353	0.00308	CcSEcCtD
Nitric Oxide—Dizziness—Ethinyl Estradiol—prostate cancer	0.000343	0.00299	CcSEcCtD
Nitric Oxide—Cardiac disorder—Etoposide—prostate cancer	0.000342	0.00299	CcSEcCtD
Nitric Oxide—Angiopathy—Etoposide—prostate cancer	0.000335	0.00292	CcSEcCtD
Nitric Oxide—Convulsion—Mitoxantrone—prostate cancer	0.000334	0.00292	CcSEcCtD
Nitric Oxide—Shock—Estradiol—prostate cancer	0.000333	0.00291	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Etoposide—prostate cancer	0.000332	0.0029	CcSEcCtD
Nitric Oxide—Nervous system disorder—Estradiol—prostate cancer	0.000332	0.0029	CcSEcCtD
Nitric Oxide—Chest pain—Mitoxantrone—prostate cancer	0.000329	0.00287	CcSEcCtD
Nitric Oxide—Headache—Ethinyl Estradiol—prostate cancer	0.000325	0.00284	CcSEcCtD
Nitric Oxide—Shock—Mitoxantrone—prostate cancer	0.00031	0.00271	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Mitoxantrone—prostate cancer	0.000308	0.00269	CcSEcCtD
Nitric Oxide—Haemoglobin—Docetaxel—prostate cancer	0.000308	0.00269	CcSEcCtD
Nitric Oxide—Haemorrhage—Docetaxel—prostate cancer	0.000307	0.00268	CcSEcCtD
Nitric Oxide—Bradycardia—Capecitabine—prostate cancer	0.000302	0.00264	CcSEcCtD
Nitric Oxide—Dyspnoea—Estradiol—prostate cancer	0.000301	0.00263	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Epirubicin—prostate cancer	0.000299	0.00261	CcSEcCtD
Nitric Oxide—Haemoglobin—Capecitabine—prostate cancer	0.000298	0.00261	CcSEcCtD
Nitric Oxide—Haemorrhage—Capecitabine—prostate cancer	0.000297	0.00259	CcSEcCtD
Nitric Oxide—Hypotension—Mitoxantrone—prostate cancer	0.000294	0.00257	CcSEcCtD
Nitric Oxide—Cardiac disorder—Docetaxel—prostate cancer	0.000284	0.00248	CcSEcCtD
Nitric Oxide—Dizziness—Goserelin—prostate cancer	0.000282	0.00246	CcSEcCtD
Nitric Oxide—Dyspnoea—Mitoxantrone—prostate cancer	0.000281	0.00245	CcSEcCtD
Nitric Oxide—Dizziness—Conjugated Estrogens—prostate cancer	0.000279	0.00244	CcSEcCtD
Nitric Oxide—Convulsion—Etoposide—prostate cancer	0.000278	0.00243	CcSEcCtD
Nitric Oxide—Angiopathy—Docetaxel—prostate cancer	0.000278	0.00243	CcSEcCtD
Nitric Oxide—Gastrointestinal haemorrhage—Doxorubicin—prostate cancer	0.000277	0.00242	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Docetaxel—prostate cancer	0.000276	0.00241	CcSEcCtD
Nitric Oxide—Cardiac disorder—Capecitabine—prostate cancer	0.000275	0.00241	CcSEcCtD
Nitric Oxide—Chest pain—Etoposide—prostate cancer	0.000273	0.00239	CcSEcCtD
Nitric Oxide—Angiopathy—Capecitabine—prostate cancer	0.000269	0.00235	CcSEcCtD
Nitric Oxide—Bradycardia—Prednisone—prostate cancer	0.000269	0.00235	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Capecitabine—prostate cancer	0.000267	0.00234	CcSEcCtD
Nitric Oxide—Headache—Goserelin—prostate cancer	0.000267	0.00233	CcSEcCtD
Nitric Oxide—Haemoglobin—Prednisone—prostate cancer	0.000266	0.00232	CcSEcCtD
Nitric Oxide—Headache—Conjugated Estrogens—prostate cancer	0.000265	0.00231	CcSEcCtD
Nitric Oxide—Haemorrhage—Prednisone—prostate cancer	0.000264	0.00231	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Etoposide—prostate cancer	0.000257	0.00224	CcSEcCtD
Nitric Oxide—Hypotension—Etoposide—prostate cancer	0.000245	0.00214	CcSEcCtD
Nitric Oxide—Angiopathy—Prednisone—prostate cancer	0.00024	0.00209	CcSEcCtD
Nitric Oxide—Dyspnoea—Etoposide—prostate cancer	0.000234	0.00204	CcSEcCtD
Nitric Oxide—Convulsion—Docetaxel—prostate cancer	0.000231	0.00202	CcSEcCtD
Nitric Oxide—Chest pain—Docetaxel—prostate cancer	0.000227	0.00198	CcSEcCtD
Nitric Oxide—Dizziness—Estradiol—prostate cancer	0.000224	0.00195	CcSEcCtD
Nitric Oxide—Chest pain—Capecitabine—prostate cancer	0.00022	0.00192	CcSEcCtD
Nitric Oxide—Shock—Docetaxel—prostate cancer	0.000214	0.00187	CcSEcCtD
Nitric Oxide—Nervous system disorder—Docetaxel—prostate cancer	0.000214	0.00187	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Docetaxel—prostate cancer	0.000213	0.00186	CcSEcCtD
Nitric Oxide—Headache—Estradiol—prostate cancer	0.000212	0.00185	CcSEcCtD
Nitric Oxide—Bradycardia—Epirubicin—prostate cancer	0.00021	0.00184	CcSEcCtD
Nitric Oxide—Haemoglobin—Epirubicin—prostate cancer	0.000208	0.00181	CcSEcCtD
Nitric Oxide—Shock—Capecitabine—prostate cancer	0.000207	0.00181	CcSEcCtD
Nitric Oxide—Nervous system disorder—Capecitabine—prostate cancer	0.000207	0.00181	CcSEcCtD
Nitric Oxide—Haemorrhage—Epirubicin—prostate cancer	0.000207	0.00181	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Capecitabine—prostate cancer	0.000206	0.0018	CcSEcCtD
Nitric Oxide—Hypotension—Docetaxel—prostate cancer	0.000203	0.00178	CcSEcCtD
Nitric Oxide—Convulsion—Prednisone—prostate cancer	0.000199	0.00174	CcSEcCtD
Nitric Oxide—Headache—Mitoxantrone—prostate cancer	0.000197	0.00172	CcSEcCtD
Nitric Oxide—Hypotension—Capecitabine—prostate cancer	0.000197	0.00172	CcSEcCtD
Nitric Oxide—Bradycardia—Doxorubicin—prostate cancer	0.000195	0.0017	CcSEcCtD
Nitric Oxide—Dyspnoea—Docetaxel—prostate cancer	0.000194	0.0017	CcSEcCtD
Nitric Oxide—Haemoglobin—Doxorubicin—prostate cancer	0.000192	0.00168	CcSEcCtD
Nitric Oxide—Cardiac disorder—Epirubicin—prostate cancer	0.000192	0.00168	CcSEcCtD
Nitric Oxide—Haemorrhage—Doxorubicin—prostate cancer	0.000191	0.00167	CcSEcCtD
Nitric Oxide—Dyspnoea—Capecitabine—prostate cancer	0.000188	0.00164	CcSEcCtD
Nitric Oxide—Angiopathy—Epirubicin—prostate cancer	0.000188	0.00164	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Epirubicin—prostate cancer	0.000186	0.00163	CcSEcCtD
Nitric Oxide—Shock—Prednisone—prostate cancer	0.000185	0.00161	CcSEcCtD
Nitric Oxide—Nervous system disorder—Prednisone—prostate cancer	0.000184	0.00161	CcSEcCtD
Nitric Oxide—Cardiac disorder—Doxorubicin—prostate cancer	0.000178	0.00155	CcSEcCtD
Nitric Oxide—Angiopathy—Doxorubicin—prostate cancer	0.000174	0.00152	CcSEcCtD
Nitric Oxide—Dizziness—Etoposide—prostate cancer	0.000173	0.00151	CcSEcCtD
Nitric Oxide—Mediastinal disorder—Doxorubicin—prostate cancer	0.000172	0.00151	CcSEcCtD
Nitric Oxide—Headache—Etoposide—prostate cancer	0.000164	0.00143	CcSEcCtD
Nitric Oxide—Convulsion—Epirubicin—prostate cancer	0.000156	0.00136	CcSEcCtD
Nitric Oxide—Chest pain—Epirubicin—prostate cancer	0.000153	0.00134	CcSEcCtD
Nitric Oxide—Shock—Epirubicin—prostate cancer	0.000145	0.00126	CcSEcCtD
Nitric Oxide—Convulsion—Doxorubicin—prostate cancer	0.000144	0.00126	CcSEcCtD
Nitric Oxide—Nervous system disorder—Epirubicin—prostate cancer	0.000144	0.00126	CcSEcCtD
Nitric Oxide—Dizziness—Docetaxel—prostate cancer	0.000144	0.00126	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Epirubicin—prostate cancer	0.000144	0.00126	CcSEcCtD
Nitric Oxide—Chest pain—Doxorubicin—prostate cancer	0.000142	0.00124	CcSEcCtD
Nitric Oxide—Dizziness—Capecitabine—prostate cancer	0.000139	0.00122	CcSEcCtD
Nitric Oxide—Hypotension—Epirubicin—prostate cancer	0.000137	0.0012	CcSEcCtD
Nitric Oxide—Headache—Docetaxel—prostate cancer	0.000136	0.00119	CcSEcCtD
Nitric Oxide—Shock—Doxorubicin—prostate cancer	0.000134	0.00117	CcSEcCtD
Nitric Oxide—Nervous system disorder—Doxorubicin—prostate cancer	0.000133	0.00116	CcSEcCtD
Nitric Oxide—Thrombocytopenia—Doxorubicin—prostate cancer	0.000133	0.00116	CcSEcCtD
Nitric Oxide—Headache—Capecitabine—prostate cancer	0.000132	0.00115	CcSEcCtD
Nitric Oxide—Dyspnoea—Epirubicin—prostate cancer	0.000131	0.00114	CcSEcCtD
Nitric Oxide—Hypotension—Doxorubicin—prostate cancer	0.000127	0.00111	CcSEcCtD
Nitric Oxide—Dizziness—Prednisone—prostate cancer	0.000124	0.00108	CcSEcCtD
Nitric Oxide—Dyspnoea—Doxorubicin—prostate cancer	0.000121	0.00106	CcSEcCtD
Nitric Oxide—Headache—Prednisone—prostate cancer	0.000118	0.00103	CcSEcCtD
Nitric Oxide—Dizziness—Epirubicin—prostate cancer	9.71e-05	0.000848	CcSEcCtD
Nitric Oxide—Headache—Epirubicin—prostate cancer	9.2e-05	0.000804	CcSEcCtD
Nitric Oxide—Dizziness—Doxorubicin—prostate cancer	8.99e-05	0.000785	CcSEcCtD
Nitric Oxide—Headache—Doxorubicin—prostate cancer	8.51e-05	0.000744	CcSEcCtD
Nitric Oxide—CYP2B6—Metabolism—NAT2—prostate cancer	1.21e-05	8.24e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—AKR1C3—prostate cancer	1.2e-05	8.12e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PRKACB—prostate cancer	1.19e-05	8.08e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CYP17A1—prostate cancer	1.18e-05	8e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP2C18—prostate cancer	1.16e-05	7.9e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PLCB2—prostate cancer	1.16e-05	7.9e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—LRP2—prostate cancer	1.16e-05	7.9e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—P4HB—prostate cancer	1.14e-05	7.75e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CKMT2—prostate cancer	1.13e-05	7.67e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GRHPR—prostate cancer	1.13e-05	7.67e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—UGT2B17—prostate cancer	1.13e-05	7.67e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—UGT2B15—prostate cancer	1.13e-05	7.67e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—NCOA2—prostate cancer	1.12e-05	7.62e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—SLC22A1—prostate cancer	1.11e-05	7.54e-05	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PTEN—prostate cancer	1.11e-05	7.54e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—HPGD—prostate cancer	1.11e-05	7.53e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—B4GALT4—prostate cancer	1.11e-05	7.53e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—SULT2A1—prostate cancer	1.08e-05	7.35e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—MED12—prostate cancer	1.06e-05	7.23e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—RFK—prostate cancer	1.06e-05	7.21e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SULT2B1—prostate cancer	1.06e-05	7.21e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PGAM2—prostate cancer	1.06e-05	7.21e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—AOX1—prostate cancer	1.06e-05	7.21e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—MBTPS1—prostate cancer	1.06e-05	7.21e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NAGLU—prostate cancer	1.06e-05	7.21e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTM3—prostate cancer	1.06e-05	7.21e-05	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—EP300—prostate cancer	1.06e-05	7.19e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GNG5—prostate cancer	1.06e-05	7.17e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—TNFRSF21—prostate cancer	1.04e-05	7.08e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—NCOA3—prostate cancer	1.02e-05	6.91e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP7B1—prostate cancer	1.01e-05	6.89e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—MTAP—prostate cancer	1.01e-05	6.89e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NAT1—prostate cancer	1.01e-05	6.84e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—DEGS1—prostate cancer	1.01e-05	6.84e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP3A43—prostate cancer	1.01e-05	6.84e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—AMACR—prostate cancer	1.01e-05	6.84e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SRD5A2—prostate cancer	1.01e-05	6.84e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—prostate cancer	9.91e-06	6.73e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SULT1E1—prostate cancer	9.88e-06	6.71e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SRD5A1—prostate cancer	9.88e-06	6.71e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—HPGDS—prostate cancer	9.7e-06	6.59e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP2C19—prostate cancer	9.64e-06	6.55e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—HSD17B1—prostate cancer	9.6e-06	6.52e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—GGT1—prostate cancer	9.6e-06	6.52e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—NCOA1—prostate cancer	9.45e-06	6.42e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ACSL4—prostate cancer	9.42e-06	6.4e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—HSD17B3—prostate cancer	9.42e-06	6.4e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ACHE—prostate cancer	9.41e-06	6.39e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTT1—prostate cancer	9.41e-06	6.39e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—prostate cancer	9.32e-06	6.33e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP2A6—prostate cancer	9.3e-06	6.32e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—AKR1C3—prostate cancer	9.04e-06	6.14e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ARG2—prostate cancer	9.04e-06	6.14e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PHGDH—prostate cancer	9.04e-06	6.14e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—UMPS—prostate cancer	9.04e-06	6.14e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PRKACB—prostate cancer	9e-06	6.11e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—RXRA—prostate cancer	8.99e-06	6.11e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP17A1—prostate cancer	8.9e-06	6.05e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—LDHB—prostate cancer	8.86e-06	6.02e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP3A5—prostate cancer	8.7e-06	5.91e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—HPGD—prostate cancer	8.55e-06	5.81e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—B4GALT4—prostate cancer	8.55e-06	5.81e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—NCOA2—prostate cancer	8.48e-06	5.76e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—UCP3—prostate cancer	8.4e-06	5.71e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PDHA1—prostate cancer	8.4e-06	5.71e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—TCN2—prostate cancer	8.4e-06	5.71e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTA3—prostate cancer	8.4e-06	5.71e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—SLC5A5—prostate cancer	8.09e-06	5.5e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—TNFRSF21—prostate cancer	8.04e-06	5.46e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SLC22A3—prostate cancer	8.01e-06	5.44e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—HSD3B1—prostate cancer	8.01e-06	5.44e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP2E1—prostate cancer	7.91e-06	5.37e-05	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—PIK3CA—prostate cancer	7.83e-06	5.32e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP7B1—prostate cancer	7.82e-06	5.32e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—MTAP—prostate cancer	7.82e-06	5.32e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—NQO1—prostate cancer	7.82e-06	5.31e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—LPL—prostate cancer	7.77e-06	5.28e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—TH—prostate cancer	7.7e-06	5.23e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—TBXAS1—prostate cancer	7.68e-06	5.22e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTA4—prostate cancer	7.68e-06	5.22e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SRD5A1—prostate cancer	7.62e-06	5.18e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SULT1E1—prostate cancer	7.62e-06	5.18e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP3A4—prostate cancer	7.62e-06	5.18e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—prostate cancer	7.51e-06	5.1e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP1B1—prostate cancer	7.49e-06	5.09e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTA2—prostate cancer	7.49e-06	5.09e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SULT1A1—prostate cancer	7.4e-06	5.02e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ABCG5—prostate cancer	7.4e-06	5.02e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ACSL4—prostate cancer	7.27e-06	4.94e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—HSD17B3—prostate cancer	7.27e-06	4.94e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GGT1—prostate cancer	7.26e-06	4.93e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTA1—prostate cancer	7.22e-06	4.91e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—NCOA1—prostate cancer	7.15e-06	4.86e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—HSD3B2—prostate cancer	7.14e-06	4.85e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTO1—prostate cancer	7.14e-06	4.85e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—NAT2—prostate cancer	7.14e-06	4.85e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP19A1—prostate cancer	7.05e-06	4.79e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ARG2—prostate cancer	6.97e-06	4.74e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—UMPS—prostate cancer	6.97e-06	4.74e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PHGDH—prostate cancer	6.97e-06	4.74e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PPARA—prostate cancer	6.87e-06	4.67e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PLCB2—prostate cancer	6.85e-06	4.65e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—LRP2—prostate cancer	6.85e-06	4.65e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP2C18—prostate cancer	6.85e-06	4.65e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—LDHB—prostate cancer	6.84e-06	4.65e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—RXRA—prostate cancer	6.8e-06	4.62e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—P4HB—prostate cancer	6.72e-06	4.56e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP3A5—prostate cancer	6.71e-06	4.56e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—COMT—prostate cancer	6.55e-06	4.45e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SLC22A1—prostate cancer	6.53e-06	4.44e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTP1—prostate cancer	6.52e-06	4.43e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—UCP3—prostate cancer	6.48e-06	4.4e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—TCN2—prostate cancer	6.48e-06	4.4e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PDHA1—prostate cancer	6.48e-06	4.4e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTA3—prostate cancer	6.48e-06	4.4e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—prostate cancer	6.46e-06	4.39e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ITPR1—prostate cancer	6.41e-06	4.36e-05	CbGpPWpGaD
Nitric Oxide—ALDH2—Metabolism—AKT1—prostate cancer	6.39e-06	4.34e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SULT2A1—prostate cancer	6.37e-06	4.33e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—MED12—prostate cancer	6.26e-06	4.26e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GNG5—prostate cancer	6.21e-06	4.22e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SLC22A3—prostate cancer	6.18e-06	4.2e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—HSD3B1—prostate cancer	6.18e-06	4.2e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—TYMS—prostate cancer	6.06e-06	4.12e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—GSTM1—prostate cancer	5.99e-06	4.07e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—NCOA3—prostate cancer	5.99e-06	4.07e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTA4—prostate cancer	5.93e-06	4.03e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—TBXAS1—prostate cancer	5.93e-06	4.03e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—prostate cancer	5.88e-06	4e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—LPL—prostate cancer	5.88e-06	4e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTA2—prostate cancer	5.78e-06	3.93e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—HPGDS—prostate cancer	5.71e-06	3.88e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SULT1A1—prostate cancer	5.71e-06	3.88e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ABCG5—prostate cancer	5.71e-06	3.88e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CYP1A1—prostate cancer	5.68e-06	3.86e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP2C19—prostate cancer	5.67e-06	3.86e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—ERCC2—prostate cancer	5.63e-06	3.83e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTA1—prostate cancer	5.57e-06	3.79e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTT1—prostate cancer	5.54e-06	3.76e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ACHE—prostate cancer	5.54e-06	3.76e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTO1—prostate cancer	5.51e-06	3.75e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—HSD3B2—prostate cancer	5.51e-06	3.75e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NAT2—prostate cancer	5.51e-06	3.75e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP2A6—prostate cancer	5.47e-06	3.72e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—CREBBP—prostate cancer	5.45e-06	3.7e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—AKR1C3—prostate cancer	5.33e-06	3.62e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PRKACB—prostate cancer	5.3e-06	3.6e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—MTHFR—prostate cancer	5.29e-06	3.6e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—LRP2—prostate cancer	5.28e-06	3.59e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PLCB2—prostate cancer	5.28e-06	3.59e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP2C18—prostate cancer	5.28e-06	3.59e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP17A1—prostate cancer	5.24e-06	3.56e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PPARA—prostate cancer	5.19e-06	3.53e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—P4HB—prostate cancer	5.18e-06	3.52e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—prostate cancer	5.17e-06	3.51e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SLC22A1—prostate cancer	5.04e-06	3.43e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—NCOA2—prostate cancer	5e-06	3.39e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SULT2A1—prostate cancer	4.91e-06	3.34e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CAV1—prostate cancer	4.88e-06	3.32e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—MED12—prostate cancer	4.83e-06	3.28e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GNG5—prostate cancer	4.8e-06	3.26e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—SLC5A5—prostate cancer	4.77e-06	3.24e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP2E1—prostate cancer	4.65e-06	3.16e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NCOA3—prostate cancer	4.62e-06	3.14e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—NQO1—prostate cancer	4.6e-06	3.13e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—TH—prostate cancer	4.54e-06	3.08e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—prostate cancer	4.51e-06	3.06e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP3A4—prostate cancer	4.49e-06	3.05e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—prostate cancer	4.47e-06	3.03e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PIK3CG—prostate cancer	4.45e-06	3.02e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP1B1—prostate cancer	4.41e-06	3e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—HPGDS—prostate cancer	4.41e-06	2.99e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP2C19—prostate cancer	4.38e-06	2.98e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ACHE—prostate cancer	4.27e-06	2.9e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTT1—prostate cancer	4.27e-06	2.9e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GGT1—prostate cancer	4.27e-06	2.9e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP2A6—prostate cancer	4.22e-06	2.87e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—INS—prostate cancer	4.21e-06	2.86e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—NCOA1—prostate cancer	4.21e-06	2.86e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP19A1—prostate cancer	4.15e-06	2.82e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—CREBBP—prostate cancer	4.12e-06	2.8e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—AKR1C3—prostate cancer	4.11e-06	2.79e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PRKACB—prostate cancer	4.09e-06	2.78e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP17A1—prostate cancer	4.05e-06	2.75e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—RXRA—prostate cancer	4e-06	2.72e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PIK3CD—prostate cancer	3.91e-06	2.66e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—prostate cancer	3.89e-06	2.65e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—COMT—prostate cancer	3.86e-06	2.62e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NCOA2—prostate cancer	3.86e-06	2.62e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTP1—prostate cancer	3.84e-06	2.61e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ITPR1—prostate cancer	3.78e-06	2.57e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—EP300—prostate cancer	3.71e-06	2.52e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—NOS3—prostate cancer	3.69e-06	2.51e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—SLC5A5—prostate cancer	3.68e-06	2.5e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP2E1—prostate cancer	3.59e-06	2.44e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—TYMS—prostate cancer	3.57e-06	2.42e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NQO1—prostate cancer	3.55e-06	2.41e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—GSTM1—prostate cancer	3.53e-06	2.4e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—TH—prostate cancer	3.5e-06	2.38e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—LPL—prostate cancer	3.46e-06	2.35e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PIK3CB—prostate cancer	3.41e-06	2.32e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP1B1—prostate cancer	3.41e-06	2.31e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PTGS2—prostate cancer	3.38e-06	2.29e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CYP1A1—prostate cancer	3.34e-06	2.27e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—ERCC2—prostate cancer	3.32e-06	2.25e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GGT1—prostate cancer	3.3e-06	2.24e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NCOA1—prostate cancer	3.25e-06	2.21e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP19A1—prostate cancer	3.2e-06	2.18e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—MTHFR—prostate cancer	3.12e-06	2.12e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—RXRA—prostate cancer	3.09e-06	2.1e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PPARA—prostate cancer	3.06e-06	2.08e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—COMT—prostate cancer	2.98e-06	2.02e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTP1—prostate cancer	2.96e-06	2.01e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PTEN—prostate cancer	2.95e-06	2e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ITPR1—prostate cancer	2.92e-06	1.98e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CAV1—prostate cancer	2.88e-06	1.95e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—EP300—prostate cancer	2.81e-06	1.91e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—TYMS—prostate cancer	2.75e-06	1.87e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—prostate cancer	2.75e-06	1.87e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—GSTM1—prostate cancer	2.72e-06	1.85e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—LPL—prostate cancer	2.67e-06	1.82e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PIK3CG—prostate cancer	2.62e-06	1.78e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CYP1A1—prostate cancer	2.58e-06	1.75e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—ERCC2—prostate cancer	2.56e-06	1.74e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—INS—prostate cancer	2.48e-06	1.68e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—CREBBP—prostate cancer	2.43e-06	1.65e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—MTHFR—prostate cancer	2.41e-06	1.63e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PPARA—prostate cancer	2.36e-06	1.6e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PIK3CD—prostate cancer	2.3e-06	1.56e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CAV1—prostate cancer	2.22e-06	1.51e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—NOS3—prostate cancer	2.17e-06	1.48e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—PIK3CA—prostate cancer	2.08e-06	1.41e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PIK3CG—prostate cancer	2.02e-06	1.37e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PIK3CB—prostate cancer	2.01e-06	1.36e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PTGS2—prostate cancer	1.99e-06	1.35e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—INS—prostate cancer	1.91e-06	1.3e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—CREBBP—prostate cancer	1.87e-06	1.27e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PIK3CD—prostate cancer	1.78e-06	1.21e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PTEN—prostate cancer	1.73e-06	1.18e-05	CbGpPWpGaD
Nitric Oxide—CYP2B6—Metabolism—AKT1—prostate cancer	1.7e-06	1.15e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—NOS3—prostate cancer	1.68e-06	1.14e-05	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—EP300—prostate cancer	1.65e-06	1.12e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PIK3CB—prostate cancer	1.55e-06	1.05e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PTGS2—prostate cancer	1.53e-06	1.04e-05	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PTEN—prostate cancer	1.34e-06	9.09e-06	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—EP300—prostate cancer	1.28e-06	8.67e-06	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—PIK3CA—prostate cancer	1.22e-06	8.31e-06	CbGpPWpGaD
Nitric Oxide—CYP1A2—Metabolism—AKT1—prostate cancer	9.99e-07	6.79e-06	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—PIK3CA—prostate cancer	9.44e-07	6.42e-06	CbGpPWpGaD
Nitric Oxide—CYP3A4—Metabolism—AKT1—prostate cancer	7.71e-07	5.24e-06	CbGpPWpGaD
